Demonstration of nanofiltration-based virus safety for AAV manufacturing using Model viruses

Authors

• Brian Buesing, Asahi Kasei Bioprocess America, Inc, USAFollow
• Tomoki Igi, Asahi Kasei Bioprocess America, Inc., 1855 Elmdale Ave., USA
• Daniel Strauss, Asahi Kasei Bioprocess America, Inc., 1855 Elmdale Ave., USA

Conference Dates

February 1 – 5, 2026

Abstract

Please click Additional Files below to see the full abstract

Recommended Citation

Brian Buesing, Tomoki Igi, and Daniel Strauss, "Demonstration of nanofiltration-based virus safety for AAV manufacturing using Model viruses" in "Advancing Manufacture of Cell and Gene Therapies IX [2026]", John Moscariello, Neuvogen, USA Corinne Hoesli, McGill University, Canada Bruno Marques, Century Therapeutics, USA Eds, ECI Symposium Series, (2026). https://dc.engconfintl.org/cell_gene_therapies_ix/90